XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance, Beginning at Dec. 31, 2022 $ 6 $ 492,665 $ (1,355) $ (144,600) $ 346,716
Balance, Beginning (in shares) at Dec. 31, 2022 63,257,376        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   21     21
Exercise of stock options (in shares) 17,356        
Stock-based compensation   3,837     3,837
Other comprehensive income (loss)     1,104   1,104
Net loss       (22,838) (22,838)
Balance, Ending at Mar. 31, 2023 $ 6 496,523 (251) (167,438) 328,840
Balance, Ending (in shares) at Mar. 31, 2023 63,274,732        
Balance, Beginning at Dec. 31, 2022 $ 6 492,665 (1,355) (144,600) 346,716
Balance, Beginning (in shares) at Dec. 31, 2022 63,257,376        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (70,020)
Balance, Ending at Sep. 30, 2023 $ 6 505,465 (424) (214,620) 290,427
Balance, Ending (in shares) at Sep. 30, 2023 63,460,939        
Balance, Beginning at Mar. 31, 2023 $ 6 496,523 (251) (167,438) 328,840
Balance, Beginning (in shares) at Mar. 31, 2023 63,274,732        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock   31     31
Exercise of stock options and vesting of restricted stock (in shares) 135,326        
Purchase of common stock under employee stock purchase plan   338     338
Purchase of common stock under employee stock purchase plan (in shares) 48,874        
Stock-based compensation   4,011     4,011
Other comprehensive income (loss)     (296)   (296)
Net loss       (21,469) (21,469)
Balance, Ending at Jun. 30, 2023 $ 6 500,903 (547) (188,907) 311,455
Balance, Ending (in shares) at Jun. 30, 2023 63,458,932        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   3     3
Exercise of stock options (in shares) 2,007        
Stock-based compensation   4,559     4,559
Other comprehensive income (loss)     123   123
Net loss       (25,713) (25,713)
Balance, Ending at Sep. 30, 2023 $ 6 505,465 (424) (214,620) 290,427
Balance, Ending (in shares) at Sep. 30, 2023 63,460,939        
Balance, Beginning at Dec. 31, 2023 $ 7 563,487 99 (244,763) $ 318,830
Balance, Beginning (in shares) at Dec. 31, 2023 70,453,342       70,453,342
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering costs $ 2 238,797     $ 238,799
Issuance of common stock, net of offering costs (in shares) 22,450,206        
Exercise of stock options   1,926     1,926
Exercise of stock options (in shares) 380,980        
Stock-based compensation   4,871     4,871
Other comprehensive income (loss)     (960)   (960)
Net loss       (28,525) (28,525)
Balance, Ending at Mar. 31, 2024 $ 9 809,081 (861) (273,288) 534,941
Balance, Ending (in shares) at Mar. 31, 2024 93,284,528        
Balance, Beginning at Dec. 31, 2023 $ 7 563,487 99 (244,763) $ 318,830
Balance, Beginning (in shares) at Dec. 31, 2023 70,453,342       70,453,342
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         $ (94,151)
Balance, Ending at Sep. 30, 2024 $ 9 826,731 1,051 (338,914) $ 488,877
Balance, Ending (in shares) at Sep. 30, 2024 94,408,911       94,408,911
Balance, Beginning at Mar. 31, 2024 $ 9 809,081 (861) (273,288) $ 534,941
Balance, Beginning (in shares) at Mar. 31, 2024 93,284,528        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock   1,577     1,577
Exercise of stock options and vesting of restricted stock (in shares) 283,039        
Purchase of common stock under employee stock purchase plan   422     422
Purchase of common stock under employee stock purchase plan (in shares) 75,774        
Stock-based compensation   5,224     5,224
Other comprehensive income (loss)     (193)   (193)
Net loss       (31,497) (31,497)
Balance, Ending at Jun. 30, 2024 $ 9 816,304 (1,054) (304,785) 510,474
Balance, Ending (in shares) at Jun. 30, 2024 93,643,341        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   3,547     3,547
Exercise of stock options (in shares) 765,570        
Stock-based compensation   6,880     6,880
Other comprehensive income (loss)     2,105   2,105
Net loss       (34,129) (34,129)
Balance, Ending at Sep. 30, 2024 $ 9 $ 826,731 $ 1,051 $ (338,914) $ 488,877
Balance, Ending (in shares) at Sep. 30, 2024 94,408,911       94,408,911